Twist Bioscience
TWST
Twist Bioscience (TWST) - Net assets
Net assets on the balance sheet as of March 2024 : $0.56 B
According to Twist Bioscience
's latest financial reports the company has $0.56 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Twist Bioscience - Net assets on balance sheet (from 2017 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-09-30 | $0.62 B | -21.02% |
| 2022-09-30 | $0.78 B | 35.91% |
| 2021-09-30 | $0.58 B | 72.73% |
| 2020-09-30 | $0.33 B | 121.11% |
| 2019-09-30 | $0.15 B | -175.5% |
| 2018-09-30 | $-0.21 B | 51.04% |
| 2017-09-30 | $-0.14 B | 74.07% |
| 2016-09-30 | $-76.62 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $6.18 M | -98.90% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $80.25 M | -85.67% | 🇬🇧 UK |
 Novavax NVAX | -$0.72 B | -227.99% | 🇺🇸 USA |
 Novocure
NVCR | $0.35 B | -35.84% | Jersey |